Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

247.10
Delayed Data
As of 3:59pm ET
 +0.78 / +0.32%
Today’s Change
184.50
Today|||52-Week Range
301.32
+17.66%
Year-to-Date
AGN Regular Dividend: AGN will begin trading ex-dividend on 02/24/17 with a $0.70 dividend payable to shareholders of record as of 02/28/17.
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
3:43pm / GuruFocus News - Paid Partner Content
North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Communi...
Feb 22 / GuruFocus News - Paid Partner Content
South Street Advisors LLC Buys The Priceline Group, PRA Health Sciences, Valvoline, S...
1:40pm / GuruFocus News - Paid Partner Content
Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top
Feb 22 / Zacks.com - Paid Partner Content
Allergan Lacks Interest in Valeant
8:39am / TheStreet.com - Paid Partner Content
Go With Allergan, Celgene and 'Big Mo'
Feb 22 / TheStreet.com - Paid Partner Content
Futures Flat, Global Stocks Near Record High After Minutes Fail To Spark Dollar Rally
7:07am / Investing Channel - Paid Partner Content
Where Are the Best Buying Opportunities in Stocks Right Now?
Feb 21 / Zacks.com - Paid Partner Content
Cramer: Buyers for Bristol-Myers Are Few and Far Between
Feb 22 / TheStreet.com - Paid Partner Content
Medtronic Earnings Rebound in Third Quarter, Shares Climb
Feb 21 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close246.32
Today’s open245.98
Day’s range244.88 - 248.55
Volume145,384
Average volume (3 months)4,750,214
Market cap$92.4B
Dividend yield1.13%
Data as of 3:59pm ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+18.85%
Earnings growth (next 5 years)+11.50%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.42+0.76%
CELGCelgene0.000.00%
LLYEli Lilly and Co+1.48+1.83%
ABBVAbbVie+0.58+0.94%
Data as of 4:00pm ET, 02/23/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$3.40
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs